STERIGENICS DENMARK A/S: Financial statements 2014
CVR: 26299691
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
STERIGENICS DENMARK A/S (CVR 26299691) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 13,463,874 and a net result of DKK 4,097,756 compared with DKK 5,158,676 the year before. That is a decrease of 1.3% compared with the year before. Equity in the 2014 report amounted to DKK 28,678,939. The solvency ratio was 52%.
- Gross Profit
- DKK 13,463,874
- Profit/Loss
- DKK 4,097,756
- Equity
- DKK 28,678,939
- Total Assets
- DKK 55,184,225
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 13.5 mio. | 4.1 mio. | 28.7 mio. | - |
| 2013 | - | 13.6 mio. | 5.2 mio. | 24.6 mio. | - |
| 2012 | - | 13.4 mio. | 2.9 mio. | 19.4 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of STERIGENICS DENMARK A/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of STERIGENICS DENMARK A/S.
STERIGENICS DENMARK A/S has published its annual report for 2013. Gross profit came to DKK 13,646,839, and the net result was DKK 5,158,676.
About STERIGENICS DENMARK A/S
STERIGENICS DENMARK A/S is a Danish company of the type Aktieselskab based in Espergærde, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named IBA S&I (DENMARK) A/S. The management consists of Maja Nøddekær. The board consists of Robin Van Der Bergh (chair), Maja Nøddekær and Ronald Victor Asselberghs. The company is owned by Nelson Labs BV. The company has 51 employees (2026). In 2025, the company reported a gross profit of DKK 45,023,268 and a net result of DKK 24,334,784 compared with DKK 25,507,602 the year before. Equity in the 2025 report amounted to DKK 44,335,784.